摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(isoquinolin-8-yloxy)ethanol | 1418287-41-8

中文名称
——
中文别名
——
英文名称
2-(isoquinolin-8-yloxy)ethanol
英文别名
2-Isoquinolin-8-yloxyethanol
2-(isoquinolin-8-yloxy)ethanol化学式
CAS
1418287-41-8
化学式
C11H11NO2
mdl
——
分子量
189.214
InChiKey
HRZFIDWYDZQDQX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    14
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    42.4
  • 氢给体数:
    1
  • 氢受体数:
    3

文献信息

  • [EN] TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF<br/>[FR] INHIBITEURS DE LA KINASE TRKA, COMPOSITIONS EN CONTENANT ET MÉTHODES ASSOCIÉES
    申请人:MERCK SHARP & DOHME
    公开号:WO2013009582A1
    公开(公告)日:2013-01-17
    The present invention is directed to compounds of formula I and la: which are tropomyosin-related kinase (Trk) family protein kinase inhibitors, and hence are useful in the treatment of pain, inflammation, cancer, restenosis, atherosclerosis, psoriasis, thrombosis, a disease, disorder, injury, or malfunction relating to dysmyelination or demyelination or a disease or disorder associated with abnormal activities of nerve growth factor (NGF) receptor TrkA.
    本发明涉及式I和la化合物,它们是原肌球蛋白相关激酶(Trk)家族蛋白激酶抑制剂,因此可用于治疗疼痛、炎症、癌症、再狭窄、动脉粥样硬化、屑病、血栓形成、与脱髓鞘或髓鞘形成障碍相关的疾病、紊乱、损伤或功能障碍,或与神经生长因子(NGF)受体TrkA异常活性相关的疾病或紊乱。
  • TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF
    申请人:Hanney Barbara
    公开号:US20140155413A1
    公开(公告)日:2014-06-05
    The present invention is directed to compounds of formula I and 1a: which are tropomyosin-related kinase (Trk) family protein kinase inhibitors, and hence are useful in the treatment of pain, inflammation, cancer, restenosis, atherosclerosis, psoriasis, thrombosis, a disease, disorder, injury, or malfunction relating to dysmyelination or demyelination or a disease or disorder associated with abnormal activities of nerve growth factor (NGF) receptor TrkA.
    本发明涉及公式I和1a的化合物,它们是肌动蛋白相关激酶(Trk)家族蛋白激酶抑制剂,因此在治疗疼痛、炎症、癌症、再狭窄、动脉粥样硬化、屑病、血栓形成、与失髓鞘或脱髓鞘有关的疾病、紊乱、损伤或功能障碍,或与神经生长因子(NGF)受体TrkA的异常活动有关的疾病或紊乱的治疗中有用。
  • US9102673B2
    申请人:——
    公开号:US9102673B2
    公开(公告)日:2015-08-11
查看更多